Ki-Chul Sung1, Seungho Ryu2, Eun Sun Cheong3, Bum Soo Kim3, Byung Jin Kim3, Yong-Bum Kim4, Pil-Wook Chung4, Sarah H Wild5, Christopher D Byrne6. 1. Division of Cardiology, Department of Medicine, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Electronic address: kcmd.sung@samsung.com. 2. Department of Occupational and Environmental Medicine, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. 3. Division of Cardiology, Department of Medicine, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. 4. Department of Neurology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. 5. Centre for Population Health Sciences, University of Edinburgh, Southampton General Hospital (University of Southampton) and Southampton National Institute for Health Research Biomedical Research Centre, Southampton, United Kingdom. 6. Nutrition and Metabolism Unit, IDS Building, Southampton General Hospital (University of Southampton) and Southampton National Institute for Health Research Biomedical Research Centre, Southampton, United Kingdom.
Abstract
INTRODUCTION: The effect of obesity on mortality in people with metabolic syndrome (MetS) risk factors, but without pre-existing diabetes; hypertension; or cardiovascular disease (CVD), is uncertain. The purpose of this study is to investigate the effect of obesity and MetS risk factors on CVD and all-cause mortality in an Asian cohort. METHODS: This retrospective study included 275,867 Koreans (56.6% men) who participated in an occupational health program between 2002 and 2009. At baseline, four groups were defined, according to the absence/presence of obesity (defined by BMI < or ≥25, respectively) and zero or one or more MetS features, respectively: metabolically healthy non-obese (MHNO; reference group); metabolically healthy obese (MHO); metabolically unhealthy obese (MUO); and metabolically unhealthy non-obese (MUNO). Hazard ratios (HRs) and 95% CIs for CVD and all-cause mortality at follow-up were estimated using Cox proportional hazards models. RESULTS: During follow-up, 1,060 deaths (187 from CVD) occurred. After adjusting for age, sex, alcohol intake, exercise, and educational status, CVD mortality risk was not increased in the MHO group (HR=0.50, 95% CI=0.15, 1.66), whereas risk was increased in the MUO and MUNO groups (HR=1.81, 95% CI=1.12, 2.91; HR=1.84, 95% CI=1.15, 2.92, respectively). HRs for all-cause mortality in both obese groups were not different from the reference group. When subjects with prior diabetes, CVD, and hypertension were excluded, CVD mortality was not significantly different in the MUO and MUNO groups from the reference group. CONCLUSIONS: Comorbid diabetes, hypertension, or CVD explain much of the increased risk of CVD mortality in obese individuals.
INTRODUCTION: The effect of obesity on mortality in people with metabolic syndrome (MetS) risk factors, but without pre-existing diabetes; hypertension; or cardiovascular disease (CVD), is uncertain. The purpose of this study is to investigate the effect of obesity and MetS risk factors on CVD and all-cause mortality in an Asian cohort. METHODS: This retrospective study included 275,867 Koreans (56.6% men) who participated in an occupational health program between 2002 and 2009. At baseline, four groups were defined, according to the absence/presence of obesity (defined by BMI < or ≥25, respectively) and zero or one or more MetS features, respectively: metabolically healthy non-obese (MHNO; reference group); metabolically healthy obese (MHO); metabolically unhealthy obese (MUO); and metabolically unhealthy non-obese (MUNO). Hazard ratios (HRs) and 95% CIs for CVD and all-cause mortality at follow-up were estimated using Cox proportional hazards models. RESULTS: During follow-up, 1,060 deaths (187 from CVD) occurred. After adjusting for age, sex, alcohol intake, exercise, and educational status, CVD mortality risk was not increased in the MHO group (HR=0.50, 95% CI=0.15, 1.66), whereas risk was increased in the MUO and MUNO groups (HR=1.81, 95% CI=1.12, 2.91; HR=1.84, 95% CI=1.15, 2.92, respectively). HRs for all-cause mortality in both obese groups were not different from the reference group. When subjects with prior diabetes, CVD, and hypertension were excluded, CVD mortality was not significantly different in the MUO and MUNO groups from the reference group. CONCLUSIONS: Comorbid diabetes, hypertension, or CVD explain much of the increased risk of CVD mortality in obese individuals.
Authors: Camille Lassale; Ioanna Tzoulaki; Karel G M Moons; Michael Sweeting; Jolanda Boer; Laura Johnson; José María Huerta; Claudia Agnoli; Heinz Freisling; Elisabete Weiderpass; Patrik Wennberg; Daphne L van der A; Larraitz Arriola; Vassiliki Benetou; Heiner Boeing; Fabrice Bonnet; Sandra M Colorado-Yohar; Gunnar Engström; Anne K Eriksen; Pietro Ferrari; Sara Grioni; Matthias Johansson; Rudolf Kaaks; Michail Katsoulis; Verena Katzke; Timothy J Key; Giuseppe Matullo; Olle Melander; Elena Molina-Portillo; Concepción Moreno-Iribas; Margareta Norberg; Kim Overvad; Salvatore Panico; J Ramón Quirós; Calogero Saieva; Guri Skeie; Annika Steffen; Magdalena Stepien; Anne Tjønneland; Antonia Trichopoulou; Rosario Tumino; Yvonne T van der Schouw; W M Monique Verschuren; Claudia Langenberg; Emanuele Di Angelantonio; Elio Riboli; Nicholas J Wareham; John Danesh; Adam S Butterworth Journal: Eur Heart J Date: 2018-02-01 Impact factor: 29.983
Authors: Nan Hee Kim; Ji A Seo; Hyunjoo Cho; Ji Hye Seo; Ji Hee Yu; Hye Jin Yoo; Sin Gon Kim; Kyung Mook Choi; Sei Hyun Baik; Dong Seop Choi; Chol Shin; Nam Han Cho Journal: Medicine (Baltimore) Date: 2016-04 Impact factor: 1.889
Authors: Maria de Fátima Haueisen Sander Diniz; Alline Maria Rezende Beleigoli; Antônio Luiz P Ribeiro; Pedro Guatimosim Vidigal; Isabela M Bensenor; Paulo A Lotufo; Bruce B Duncan; Maria Inês Schmidt; Sandhi Maria Barreto Journal: Medicine (Baltimore) Date: 2016-07 Impact factor: 1.889
Authors: Enrique Rodriguez-Garcia; Josefina Ruiz-Nava; Sonia Santamaria-Fernandez; Jose Carlos Fernandez-Garcia; Antonio Vargas-Candela; Raquel Yahyaoui; Francisco J Tinahones; Maria Rosa Bernal-Lopez; Ricardo Gomez-Huelgas Journal: Medicine (Baltimore) Date: 2017-07 Impact factor: 1.889